Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Santarus, Inc.    SNTS   US8028173040

SANTARUS, INC.

 (SNTS)

10
SummaryQuotesChart AnalysisNewsAnalysisCalendarCompanyFinancialsConsensusRevisionsForum 
Latest news on SANTARUS, INC.
1d ago SANTARUS, INC.: Santarus Announces UCERIS (budesonide) Poster Presentations at ..
3d ago SANTARUS, INC.: Santarus Announces Exercise in Full of Option to Purchase Addit..
05/10 SANTARUS, INC.: Santarus Announces Pricing of Secondary Common Stock Offering b..
05/09 SANTARUS, INC.: Santarus Announces Launch of a Proposed Secondary Common Stock ..
05/07DJU.S. HOT STOCK FUTURES: Hot stocks to watch
05/06 SANTARUS, INC.: Santarus Reports First Quarter 2013 Financial Results
05/03 SANTARUS, INC.: Santarus to Present at May and June Investment Conferences
05/02 SANTARUS, INC.: CYCLOSET (bromocriptine mesylate) Included in American Associat..
04/22 SANTARUS, INC.: Santarus to Hold First Quarter 2013 Financial Results Conferenc..
03/26 SANTARUS, INC.: Santarus to Host Investor and Analyst Day on April 11, 2013
03/22 SANTARUS, INC.: Before the Bell Scans of MannKind, Ariad Pharma, ZIOPHARM Oncol..
03/18 SANTARUS, INC.: Santarus Announces Publication in Gut of Results from UCERIS (b..
03/06 SANTARUS, INC.: Santarus and VeroScience Announce Publication of AACE Expert Pa..
03/05DJMARKET SNAPSHOT: U.S. Stocks Rally To Lift Dow To New Heights
03/05DJU.S. Stock Futures Rally; Dow Set To Open Above Record High
03/05DJU.S. HOT STOCK FUTURES: Hot stocks to watch
03/05DJU.S. HOT STOCK FUTURES: Hot stocks to watch
03/04 SANTARUS, INC.: Santarus Reports Fourth Quarter and Full Year 2012 Financial Re..
02/27SANTARUS, INC.: quaterly earnings release
02/27 SANTARUS, INC.: Santarus to Present at March Investment Conferences
02/19 SANTARUS, INC.: Santarus to Hold Fourth Quarter and Full Year 2012 Financial Re..
02/14 SANTARUS, INC.: Santarus Announces Commercial Launch of UCERIS (budesonide) Ext..
02/06 SANTARUS, INC.: Santarus to Present at Leerink Swann Global Healthcare Conferen..
01/23 SANTARUS, INC.: Santarus and VeroScience Announce Publication of Positive Data ..
01/15DJU.S. HOT STOCK FUTURES: Hot stocks to watch
01/14 SANTARUS, INC.: Santarus Receives FDA Approval of UCERIS (Budesonide) for the I..
2012 SANTARUS, INC.: Santarus Reports Third Quarter 2012 Financial Results
2012 SANTARUS, INC.: Santarus and Pharming Announce Positive Top-Line Phase III Resu..
2012 SANTARUS, INC.: Santarus to Present at November Investor Conferences
2012SANTARUS, INC.: quaterly earnings release
2012 SANTARUS, INC.: Santarus to Hold Third Quarter 2012 Financial Results Conferenc..
2012 SANTARUS, INC.: Santarus Announces Publication of Results from UCERIS Pivotal S..
2012DJU.S. HOT STOCK FUTURES: Hot stocks to watch
2012DJU.S. HOT STOCK FUTURES: Hot stocks to watch
2012 SANTARUS, INC.: Santarus Announces Positive Top-Line Phase III Results for Rifa..
2012 SANTARUS, INC.: Santarus Announces Appellate Court Reversal in Part of ZEGERID ..
2012 SANTARUS, INC.: Santarus to Present at September Investment Conferences
2012 SANTARUS, INC.: Santarus Announces FDA Extension of UCERIS New Drug Application..
2012 SANTARUS, INC.: Santarus Reports Second Quarter 2012 Financial Results
2012 SANTARUS, INC.: Santarus to Hold Second Quarter 2012 Financial Results Conferen..
2012 SANTARUS, INC.: Santarus to Present at Seventh Annual JMP Securities Healthcare..
2012 SANTARUS, INC.: Santarus to Present at Jefferies 2012 Global Healthcare Confere..
2012 SANTARUS, INC.: Santarus Announces Presentation of UCERIS Phase III Extended Us..
2012 SANTARUS, INC.: Santarus Reports First Quarter 2012 Financial Results
2012 SANTARUS, INC.: Santarus to Present at Bank of America Merrill Lynch 2012 Healt..
2012 SANTARUS, INC.: Santarus to Hold First Quarter 2012 Financial Results Conferenc..
2012 SANTARUS, INC.: Santarus Appoints Alessandro E. Della Chà and Matthew W. Strobe..
2012 SANTARUS, INC.: Santarus to Present at 11th Annual Needham Healthcare Conferenc..
2012 SANTARUS, INC.: Santarus Reports Fourth Quarter and Full Year 2011 Financial Re..
2012 SANTARUS, INC.: Santarus to Present at March Investment Conferences
2012 SANTARUS, INC.: Santarus to Hold Fourth Quarter and Full Year 2011 Financial Re..
2012DJLupin Settles Patent Dispute Over Glumetza Diabetes Treatment
2012 SANTARUS, INC.: Santarus and Depomed Announce Settlement with Lupin of GLUMETZA..
2012 SANTARUS, INC.: Santarus Announces FDA Acceptance of UCERIS New Drug Applicatio..
2012 SANTARUS, INC.: Santarus Increases Revolving Line of Credit to $35 Million and ..
2012 SANTARUS, INC.: Santarus Announces Initiation of Phase IIIb Study with UCERIS i..
2012 SANTARUS, INC.: Santarus Begins Promoting Cholesterol-Lowering Product FENOGLID..
2011 SANTARUS, INC.: Santarus Adds FENOGLIDE to Marketed Products Portfolio
2011 SANTARUS, INC.: Santarus Submits New Drug Application to FDA for UCERIS (budeso..
2011 SANTARUS, INC.: Santarus and Pharming Announce Oral Presentations of Retrospect..
2011 SANTARUS, INC.: Santarus Announces Presentation of New Open-Label UCERIS (Budes..
2011 SANTARUS, INC.: Santarus to Present at November Investment Conferences
2011 SANTARUS, INC.: Santarus Reports Third Quarter 2011 Financial Results
2011 SANTARUS, INC.: Santarus and Pharming Announce Presentation of Retrospective An..
2011 SANTARUS, INC.: Santarus Announces Presentation of Pooled Data from Budesonide ..
2011 SANTARUS, INC.: Santarus to Hold Third Quarter 2011 Financial Results Conferenc..
2011 SANTARUS, INC.: Santarus Announces Supportive Top-Line Results from Budesonide ..
2011 SANTARUS: to Present at September Investment Conferences
2011 SANTARUS: and Depomed Announce New U.S. Commercialization Agreement for GLUMETZ..
2011 SANTARUS: to Present at the 2011 Wedbush Life Sciences: Management Access Confe..
2011 SANTARUS: Reports Second Quarter 2011 Financial Results
2011 SANTARUS: to Hold Second Quarter 2011 Financial Results Conference Call on Augu..
2011 SANTARUS: Appoints Wendell Wierenga Executive Vice President, Research and Deve..
2011 SANTARUS: to Present at the Wells Fargo Securities 2011 Healthcare Conference
2011 SANTARUS: Announces Presentation of RHUCIN Clinical Data at 7th C1 Inhibitor De..
1  2Next
Advertisement
Chart
Duration : Period :
Santarus, Inc. Technical Analysis Chart | SNTS | US8028173040 | 4-Traders
Income Statement Evolution
Santarus, Inc. : Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF
Copyright © 2013 Surperformance. All rights reserved.